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Summary
Background The aim was to evaluate and correlate anxiety and
depression levels with response to neoadjuvant chemotherapy in patients
with breast cancer. The study also assessed the effects of family support
on distress levels.
Design It was a prospective study in a cohort of 84 patients with locally
advanced breast cancer. These assessments were done using the Hospital
Anxiety and Depression Scale (HADS).
Setting A prospective study in a developing world setting.
Participants Eighty-four patients with locally advanced breast cancer
receiving neoadjuvant chemotherapy were included after taking an
informed consent and ethical committee clearance.
Main outcome measures A signiﬁcant correlation was observed
between response to neoadjuvant chemotherapy and depression levels in
breast cancer patients. Joint family and literacy levels also had an impact
on the levels of depression observed.
Results A total of 84 patients receiving neoadjuvant chemotherapy for
breast cancer were evaluated using HADS. The effect of family support,
literacy levels and employment on the psychological status of these
patients were also assessed.
Conclusions The response to neoadjuvant chemotherapy had a direct
correlation with the levels of depression, the distress levels being lower in
responders. This was found to be the most important variable
determining the psychological status of the patients. It was also observed
that Indian patients in comparison to their Western counterparts react
differently to cancer-related stress.
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RESEARCH
1Background
Neoadjuvant chemotherapy is an integral part of
the multi-modality approach to the management
of locally advanced breast cancer.
1–5 Chemother-
apy, which the patients are subjected to, involves
long periods of treatment, repeated hospitaliz-
ations, and side-effects such as nausea, vomiting
and alopecia. Cancer diagnosis and treatment
have been shown to have profound effects on the
psychological status of patients.
6–9 The initial
response to a diagnosis of cancer ranges from
shock and disbelief, to symptoms of dysphoria,
irritability, loss of appetite and sleep disturbances.
The intense chemotherapy administered can
further add up to the psychological distress and
the majority of these patients show adjustment
disorders with symptoms of mixed anxiety and
depression. Thus, the morbidity caused by
cancer and its treatment is not entirely phys-
ical.
6–9It has been observed that the psychological
adjustment to cancer depends on several medical
(stage of the disease, site and size of the tumor),
sociocultural (attitudes, beliefs and means of
support) and patient-related factors (personality
types, coping mechanisms, pre-existing psychia-
tric illnesses).
6–8There are numerous implications
of distress and depressive states in cancer patients.
These states, while acting as a burden for the
patient and her family, also cause increased pain
perception associated with longer hospital stays,
decreased compliance to therapy and hence
decreased response, and most importantly severe
depression associated with an increased risk of
suicide. Hence, it is essential to identify and
appropriately manage the distress and depression
in cancer patients in a timely manner.
6–8In devel-
oped countries there are guidelines and protocols
followed by a hierarchy of social workers and
mental health professionals for the management
of distress in cancer patients, for example the
NCCN Guidelines in the USA and CAPO guide-
lines in Canada. But in developing countries
where there are limited medical resources, distress
management is mostly provided by the family
members, traditional healers and religious
workers.
With this background in mind, the present
study was undertaken with the aim of assessing
the levels of anxiety and depression in breast
cancer patients in the Indian scenario and to
correlate these levels with response to neoadju-
vant chemotherapy. This was done by using the
Hospital Anxiety and Depression Scale (HADS).
We also tried to identify other contributing
factors to the level of depression in these patients,
such as education and employment of patients.
To identify the effect of family support on the
psychological status of patients, the correlation
between depression and type of family (joint or
nuclear) the patients belonged to, was also
analysed.
Methodology
The levels of anxiety and depression of breast
cancer patients in Safdarjung Hospital, New
Delhi were assessed using the Hospital Anxiety
and Depression Scale (HADS). HADS is a
14-item instrument designed to assess the levels
of anxiety and depression. Each item was
answered by the patient on a four-point (0–3)
response category so the possible scores ranged
from 0–21 for anxiety and 0–21 for depression.
An analysis of scores on the two subscales of a
further sample, in the same clinical setting,
enabled provision of information that a score of
0–7 for either subscale could be regarded as
being in the normal range, a score of 11 or
higher indicating probable presence (‘caseness’)
of the mood disorder and a score of 8–10 being
just suggestive of the presence of the respective
state.
9–11
A total of 84 patients receiving neoadjuvant
chemotherapy (CAF Regime) were evaluated.
Written informed consent was taken and the
patients were interviewed at each step of disease
management, right from the time of diagnosis to
get a baseline distress level, then after each cycle
of neoadjuvant chemotherapy, post surgery, and
aftereach cycle of chemotherapy. These interviews
were carried out while thepatients werewaiting in
day care for their session of chemotherapy. In
addition to the HADS questionnaire, personal
details like the demographic proﬁle, religion,
marital status and details of family were also col-
lected after taking the informed consent from the
patients.
The patients were categorized into two groups
based on their response to therapy: responders
and non-responders; the criteria for response
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2being a reduction of more than 50% in the tumor
size on clinical assessment after three cycles
of neoadjuvant chemotherapy. The levels of
depression were correlated with the number of
neoadjuvant chemotherapy cycles and the clinical
response, education, occupation and the type of
family the patient belonged to. Statistical analysis
was carried out by using SPSS version 14.0.
Results
Cohort distribution
Based on the criterion stated above, 49 patients
(58.3%) were found to be responders to the neoad-
juvant chemotherapy, while 35 (41.7%) patients
did not respond to chemotherapy. The majority
of our patients were illiterate (46, 54.7%) and
housewives (68, 79.7%). The distribution of
patients into joint and nuclear families was equal
(50% in each category).
As the patients were interviewed at each step of
disease management, the number of neoadjuvant
chemotherapy cycles received varied, and thus
the effect of the number of cycles to response, tox-
icity and psychological status could be assessed.
Fifty-one (60.7%) patients received three cycles
or less of chemotherapy whereas 33 (39.3%)
patients received more than three chemotherapy
cycles. All 84 patients completed their scheduled
neoadjuvant therapy.
Observations
None of the patients included in this study had
any form of depression before the diagnosis of
breast cancer. The mean depression scores in the
breast cancer patients included in this study was
4.9 (range 1–6).
The mean depression score in responders after
neoadjuvant chemotherapy was found to be 5.6
(range 1–16), whereas the mean score in non-
responders was 10.2 (range 4–20).
Twenty-four (70.5%) non-responders were
found to suffer from depression compared with
only 11 (22.0%) of the responders (Table 1). Thus,
the correlation of depression and response to
neoadjuvant chemotherapy was found to be stat-
istically signiﬁcant (chi-square test, P value
<0.05).
Seventeen (51.5%) of the 33 patients who
received more than three neoadjuvant chemother-
apy cycles showed depression, while 33 (64.7%) of
the 51 patients who had received less than three
cycles did not suffer from depression (Table 2).
This correlation, however, was not found to be
statistically signiﬁcant. Thus, the number of
cycles of neoadjuvant chemotherapy does not
appear to be as important a criterion as the
response to chemotherapy cycles for determining
the psychological status of the patients.
Depression was found to be higher in literate
(25, 54.3%) and employed (14, 53.8%) patients.
However, these data were not found to be statisti-
cally signiﬁcant.
An interesting observation in our study, wasthe
effect of the type of family on the patient’s psycho-
logical status (Table 3). It was seen that 24 (57.1%)
patients from nuclear families showed signiﬁcant
levels of depression, in contrast to the 11 (36.2%)
patients of joint families (p <0.05). Thus, family
support provided by the members appears to
improve the psychological status of a cancer
patient.
All patients completed their neoadjuvant che-
motherapy regimes and there were no dropouts
during this period on account of depression
and/or anxiety.
Table 1
The presence or absence of depression in patients undergoing
neoadjuvant chemotherapy
Depression Non-responder Responder Total
No 10 (29.5%) 39 (78.0%) 49
Yes 24 (70.5%) 11 (22.0%) 35
Total 34 50 84
Table 2
The correlation between number of neoadjuvant
chemotherapy cycles received and depression
Depression 3 >3 Total
No 33 (64.7%) 16 (48.5%) 49
Yes 18 (35.3%) 17 (51.5%) 35
Total 51 33 84
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3Discussion
The analysis of the data collected has shown that
neoadjuvant chemotherapy had a physical as
well as a psycho-social impact on patients. None
of these patients had depression before
the initiation of neoadjuvant chemotherapy,
suggesting that neoadjuvant chemotherapy had
a major role in the development of depression in
some of the patients. Most patients were troubled
by the side-effects of nausea and alopecia after the
chemotherapy cycles, however, these lasted for a
short duration, after which a signiﬁcant pro-
portion of patients were relieved and showed
lower anxiety and depression levels due to the
diminished lump size and reduced pain, an indi-
cation that they were likely to be cured of the
deadly cancer. This observation was reﬂected in
the ﬁnding that only 70.5% of non-responders
were found to suffer from depression compared
with only 22.0% of the responders. Thus, response
to chemotherapy correlated signiﬁcantly (p <0.05)
with the improvement in psychological status of
our patients. Contrary to our expectations, none
of the depressed patients were defaulters and
this can be possibly explained, by the strong
social support system available to them.
As compared to the results of the studies con-
ducted in the developed world,
6–8 the Indian
counterparts of breast cancer patients showed
lower anxiety and depression levels. This can
probably be attributed to their lower socioeco-
nomic status (most patients in this study were in
the lower middle and lower class according to
the Kuppuswami scale), consequently leading to
lower educational status. Being uneducated and
not having much knowledge about the nature of
the disease they were suffering from, lead to a
carefree attitude about the illness. Another
reason for the lower anxiety and depression
levels in our patients could possibly be the pres-
ence of emotional and ﬁnancial support offered
by the family members of the patients, as it was
observed in our study that a higher percentage
of patients living in joint families showed lower
rates of depression.
On the other hand, this lower literacy level also
lead to few misconceptions about the disease, for
instance, some patients thinking of cancer as a
contagious disease which could spread by direct
contact to their loved ones. This in turn leads to
doubts and apprehensions, feelings of vulner-
ability and a tendency of social isolation.
Among other causes of anxiety and depression
were worries concerning their households, loss of
jobs leading to ﬁnancial insecurity, and adjust-
ment disorders on coming to a metropolitan city
from a village. Many patients showed higher
levels of anxiety for a few days before surgery.
Conclusions
Most Indian patients present as locally advanced
breast cancer and require neoadjuvant chemother-
apy, which improves the survival rates but has
associated morbidity, which is not entirely phys-
ical. The response to neoadjuvant chemotherapy
cycles has a direct correlation with depression,
the distress levels being lower in responders. Stat-
istically this was found to be the most important
variable determining the psychological status of
the patients. Although the distress levels were
slightly higher in patients with more than three
cycles on account of the increased side-effects of
the drugs, this was not found to be statistically
signiﬁcant.
An association between socioeconomic status
and levels of education, with anxiety and
depression seems likely, however, a larger study
group is required so that the signiﬁcance of these
preliminary results can be veriﬁed by statistical
methods. Family support plays a vital role in
improving the psychological status of the patients.
It seems that Indian patients in comparison to
their Western counterparts react differently to
cancer-related stress. Perhaps patients in the
present study behaved differently than those in
the West, thus ‘a local solution to a local
problem’ is necessary requiring larger studies.
Table 3
The correlation between the type of family and
depression in patients undergoing neoadjuvant
chemotherapy
Depression Joint family Nuclear family Total
No 31 (73.8%) 18 (42.9%) 49
Yes 11 (26.2%) 24 (57.1%) 35
Total 42 42 84
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4Many questionnaires devised in the West have
been standardized to assess the psychological
status of cancer patients throughout the world,
one of which HADS was used in this study. But
some questions seemed unsuitable for our
patients; hence a questionnaire for the Indian
set-up is desirable. A system for spreading aware-
ness about breast cancer will go a long way in
allaying the unfounded fears and misconceptions
of our patients. Psychological interventions like
psychotherapies, behavioral and relaxation tech-
niques, art therapies and methods of spiritual
healing can be tried to relieve the psychological
distress, while patients with severe depression
should seek psychiatric treatment including
pharmacological agents.
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